Přejít k obsahu
Merck
  • Solid-Phase Thiol-Ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist.

Solid-Phase Thiol-Ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist.

Angewandte Chemie (International ed. in English) (2018-07-07)
Elyse T Williams, Paul W R Harris, Muhammad A Jamaluddin, Kerry M Loomes, Debbie L Hay, Margaret A Brimble
ANOTACE

We report a new method herein coined SP-CLipPA (solid-phase cysteine lipidation of a peptide or amino acid) for the synthesis of mono-S-lipidated peptides. This technique utilizes thiol-ene chemistry for conjugation of a vinyl ester to a free thiol of a semiprotected, resin-bound peptide. Advantages of SP-CLipPA include: ease of handling, conversions of up to 91 %, by-product removal by simple filtration, and a single purification step. Additionally, the desired lipidated products show high chromatographic separation from impurities, thus facilitating RP-HPLC purification. To showcase the utility of SP-CLipPA, we synthesized a potent calcitonin gene-related peptide (CGRP) receptor antagonist peptide in excellent yield and purity. This peptide, selected from a series of lipidated analogues of CGRP8-37 and CGRP7-37 , has potential for the treatment of migraine.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Fmoc-Cys(4-methoxytrityl)-OH, ≥98% (HPLC)